DE1568006A1 - Verfahren zur Herstellung von Oestradienderivaten - Google Patents
Verfahren zur Herstellung von OestradienderivatenInfo
- Publication number
- DE1568006A1 DE1568006A1 DE19661568006 DE1568006A DE1568006A1 DE 1568006 A1 DE1568006 A1 DE 1568006A1 DE 19661568006 DE19661568006 DE 19661568006 DE 1568006 A DE1568006 A DE 1568006A DE 1568006 A1 DE1568006 A1 DE 1568006A1
- Authority
- DE
- Germany
- Prior art keywords
- sodium borohydride
- dione
- substituted
- hydride
- production
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 238000004519 manufacturing process Methods 0.000 title claims description 6
- 238000000034 method Methods 0.000 title claims description 4
- OSVMTWJCGUFAOD-KZQROQTASA-N formestane Chemical compound O=C1CC[C@]2(C)[C@H]3CC[C@](C)(C(CC4)=O)[C@@H]4[C@@H]3CCC2=C1O OSVMTWJCGUFAOD-KZQROQTASA-N 0.000 claims description 10
- 239000012279 sodium borohydride Substances 0.000 claims description 10
- 229910000033 sodium borohydride Inorganic materials 0.000 claims description 10
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 claims description 5
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 claims description 4
- JFBZPFYRPYOZCQ-UHFFFAOYSA-N [Li].[Al] Chemical compound [Li].[Al] JFBZPFYRPYOZCQ-UHFFFAOYSA-N 0.000 claims description 4
- 150000004678 hydrides Chemical class 0.000 claims description 4
- 239000011701 zinc Substances 0.000 claims description 3
- 229910052725 zinc Inorganic materials 0.000 claims description 3
- 229910052757 nitrogen Inorganic materials 0.000 claims description 2
- QZLYKIGBANMMBK-UGCZWRCOSA-N 5α-Androstane Chemical compound C([C@@H]1CC2)CCC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CCC[C@@]2(C)CC1 QZLYKIGBANMMBK-UGCZWRCOSA-N 0.000 claims 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 claims 1
- 239000007795 chemical reaction product Substances 0.000 claims 1
- 230000001076 estrogenic effect Effects 0.000 claims 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims 1
- 150000002576 ketones Chemical class 0.000 claims 1
- 239000001301 oxygen Substances 0.000 claims 1
- 229910052760 oxygen Inorganic materials 0.000 claims 1
- 150000003839 salts Chemical class 0.000 claims 1
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 21
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 15
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 10
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 9
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 8
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 6
- WKRLQDKEXYKHJB-UHFFFAOYSA-N Equilin Natural products OC1=CC=C2C3CCC(C)(C(CC4)=O)C4C3=CCC2=C1 WKRLQDKEXYKHJB-UHFFFAOYSA-N 0.000 description 5
- 150000001875 compounds Chemical class 0.000 description 5
- WKRLQDKEXYKHJB-HFTRVMKXSA-N equilin Chemical compound OC1=CC=C2[C@H]3CC[C@](C)(C(CC4)=O)[C@@H]4C3=CCC2=C1 WKRLQDKEXYKHJB-HFTRVMKXSA-N 0.000 description 5
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 5
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 4
- 238000000605 extraction Methods 0.000 description 4
- 239000000203 mixture Substances 0.000 description 4
- 238000001953 recrystallisation Methods 0.000 description 4
- 239000002904 solvent Substances 0.000 description 4
- 238000010790 dilution Methods 0.000 description 3
- 239000012895 dilution Substances 0.000 description 3
- 238000001704 evaporation Methods 0.000 description 3
- 230000008020 evaporation Effects 0.000 description 3
- 238000001914 filtration Methods 0.000 description 3
- 235000015097 nutrients Nutrition 0.000 description 3
- 239000000243 solution Substances 0.000 description 3
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 3
- 238000004809 thin layer chromatography Methods 0.000 description 3
- 238000006243 chemical reaction Methods 0.000 description 2
- 238000004587 chromatography analysis Methods 0.000 description 2
- 229940011871 estrogen Drugs 0.000 description 2
- 239000000262 estrogen Substances 0.000 description 2
- 239000012280 lithium aluminium hydride Substances 0.000 description 2
- -1 lithium aluminum hydride Chemical compound 0.000 description 2
- 238000002844 melting Methods 0.000 description 2
- 230000008018 melting Effects 0.000 description 2
- 230000002906 microbiologic effect Effects 0.000 description 2
- 239000012299 nitrogen atmosphere Substances 0.000 description 2
- 239000007858 starting material Substances 0.000 description 2
- 150000003431 steroids Chemical class 0.000 description 2
- 238000010626 work up procedure Methods 0.000 description 2
- KSNANLKEQVBAHL-PBWTXFEYSA-N (9S,10S,13S,14S)-10-(hydroxymethyl)-13-methyl-2,6,9,11,12,14,15,16-octahydro-1H-cyclopenta[a]phenanthrene-3,17-dione Chemical compound O=C1CC[C@]2(CO)[C@H]3CC[C@](C)(C(CC4)=O)[C@@H]4C3=CCC2=C1 KSNANLKEQVBAHL-PBWTXFEYSA-N 0.000 description 1
- WSLDOOZREJYCGB-UHFFFAOYSA-N 1,2-Dichloroethane Chemical compound ClCCCl WSLDOOZREJYCGB-UHFFFAOYSA-N 0.000 description 1
- 241000272201 Columbiformes Species 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- WHXSMMKQMYFTQS-UHFFFAOYSA-N Lithium Chemical compound [Li] WHXSMMKQMYFTQS-UHFFFAOYSA-N 0.000 description 1
- 240000008042 Zea mays Species 0.000 description 1
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 1
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 1
- 230000001833 anti-estrogenic effect Effects 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 235000013405 beer Nutrition 0.000 description 1
- 125000004106 butoxy group Chemical group [*]OC([H])([H])C([H])([H])C(C([H])([H])[H])([H])[H] 0.000 description 1
- 210000002318 cardia Anatomy 0.000 description 1
- 239000006285 cell suspension Substances 0.000 description 1
- HRYZWHHZPQKTII-UHFFFAOYSA-N chloroethane Chemical compound CCCl HRYZWHHZPQKTII-UHFFFAOYSA-N 0.000 description 1
- 239000004927 clay Substances 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 229940125898 compound 5 Drugs 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- 235000005822 corn Nutrition 0.000 description 1
- 238000002425 crystallisation Methods 0.000 description 1
- 230000008025 crystallization Effects 0.000 description 1
- PDRGHUMCVRDZLQ-UHFFFAOYSA-N d-equilenin Natural products OC1=CC=C2C(CCC3(C4CCC3=O)C)=C4C=CC2=C1 PDRGHUMCVRDZLQ-UHFFFAOYSA-N 0.000 description 1
- 125000005594 diketone group Chemical group 0.000 description 1
- 238000007865 diluting Methods 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- PDRGHUMCVRDZLQ-WMZOPIPTSA-N equilenin Chemical compound OC1=CC=C2C(CC[C@]3([C@H]4CCC3=O)C)=C4C=CC2=C1 PDRGHUMCVRDZLQ-WMZOPIPTSA-N 0.000 description 1
- 229960003750 ethyl chloride Drugs 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 229910052744 lithium Inorganic materials 0.000 description 1
- 125000006574 non-aromatic ring group Chemical group 0.000 description 1
- 239000008055 phosphate buffer solution Substances 0.000 description 1
- 239000003531 protein hydrolysate Substances 0.000 description 1
- 238000000197 pyrolysis Methods 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
- A61K31/566—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol having an oxo group in position 17, e.g. estrone
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J75/00—Processes for the preparation of steroids in general
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S435/00—Chemistry: molecular biology and microbiology
- Y10S435/8215—Microorganisms
- Y10S435/822—Microorganisms using bacteria or actinomycetales
- Y10S435/872—Nocardia
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Epidemiology (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Steroid Compounds (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US452886A US3340278A (en) | 1965-05-03 | 1965-05-03 | 5(10), 7-estradiene-3, 17-dione and the process for the production thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DE1568006A1 true DE1568006A1 (de) | 1970-02-12 |
Family
ID=23798354
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE19661568006 Pending DE1568006A1 (de) | 1965-05-03 | 1966-05-03 | Verfahren zur Herstellung von Oestradienderivaten |
Country Status (6)
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3445487A (en) * | 1965-06-22 | 1969-05-20 | Glaxo Lab Ltd | Process for the preparation of 3-oxo-4,6-dehydro-19-nor-steroids |
| GB1151865A (en) * | 1965-06-22 | 1969-05-14 | Glaxo Lab Ltd | Process for the production of 5(10), 7-Dehydrosteroids |
| US3472883A (en) * | 1967-07-05 | 1969-10-14 | American Home Prod | Process for preparing estren-3-ones |
| US6458778B1 (en) | 1997-04-07 | 2002-10-01 | Wyeth | Estradienes |
| ES2200334T3 (es) * | 1997-04-07 | 2004-03-01 | Wyeth | Estra-5(10),7-dieno con actividad estrogenica. |
-
1965
- 1965-05-03 US US452886A patent/US3340278A/en not_active Expired - Lifetime
-
1966
- 1966-04-27 GB GB18496/66A patent/GB1127128A/en not_active Expired
- 1966-04-28 IL IL25649A patent/IL25649A/en unknown
- 1966-05-03 NL NL6605955A patent/NL6605955A/xx unknown
- 1966-05-03 DE DE19661568006 patent/DE1568006A1/de active Pending
- 1966-05-03 CH CH637566A patent/CH454846A/fr unknown
Also Published As
| Publication number | Publication date |
|---|---|
| IL25649A (en) | 1970-02-19 |
| NL6605955A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) | 1966-11-04 |
| GB1127128A (en) | 1968-09-11 |
| CH454846A (fr) | 1968-04-30 |
| US3340278A (en) | 1967-09-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE1568006A1 (de) | Verfahren zur Herstellung von Oestradienderivaten | |
| DE936207C (de) | Verfahren zur Herstellung von oxydierten Steroiden | |
| US3523870A (en) | Steroid transformation by enzymes of aspergillus tamarii | |
| DE1593687C (de) | Verfahren zur Herstellung von neuen Benzo eckige Klammer auf d,e eckige Klam mer zu steroiden der Androstan und Preg nanreihe | |
| DE959188C (de) | Verfahren zur Herstellung von 17-Ketotestanen und 17-Ketoandrostanen | |
| AT212498B (de) | Verfahren zur mikrobiologischen Oxydation von Steroiden | |
| DE1593327C (de) | Verfahren zur Herstellung von Delta hoch 1,4 -Androstadien-3,17-dion, Delta hoch 1,4 -Androstadien-3,11,17-trion bzw. Delta hoch 1,4 -Androstadien-1 lalpha-ol-3,17-dion | |
| AT233175B (de) | Verfahren zur Herstellung von 3-Oxo-Δ<1,4>- und 3-Oxo-Δ<1,4,6>-steroiden | |
| AT235476B (de) | Verfahren zur Herstellung der neuen 11β,21-Dihydroxy-16α-alkyl-4,17(20)-pregnadien-3-one | |
| DE1037450B (de) | Verfahren zur Oxydation von gesaettigten und ungesaettigten 21-Hydroxysteroiden der Pregnanreihe | |
| CH349978A (de) | Verfahren zur mikrobiologischen 1-Dehydrierung von Steroiden | |
| DE1027667B (de) | Verfahren zur Herstellung polyoxigenierter Pregnane | |
| CH335492A (de) | Verfahren zur Herstellung von 17-Oxy-steroiden | |
| DE2445161A1 (de) | D-homo-20-ketopregnane ii | |
| DE1593327A1 (de) | Verfahren fuer mikrobiologische Herstellung von Steroiden mit 1,4-Dien-3,17-Dion-Struktur | |
| DE1005961B (de) | Verfahren zur Herstellung von Polyoxysteroiden der Pregnanreihe | |
| DE1226575B (de) | Verfahren zur Darstellung von 11beta-hydroxylierten 16alpha-Methylsteroiden der Pregnanreihe | |
| DE1172669B (de) | Verfahren zur Herstellung von 11-oxygenierten 16ª‰-(2', 2'-Dicarboxyaethyl)-3,17-diketo-steroiden bzw. von deren 1-Dehydroderivaten | |
| DE1249272B (de) | Verfah ren zur Herstellung eines neuen 14a Hydroxy steroids | |
| DEU0003001MA (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) | ||
| DE1159440B (de) | Verfahren zur Herstellung von í¸-Pregnen-6,20ª-diol-3-on bzw. des isomeren Allopregnan-20ª-ol-3,6-dions sowie ihrer Ester | |
| DE1013648B (de) | Verfahren zur Kernoxydation von in 4(5)-Stellung ungesaettigten 3-Ketosteroiden | |
| DE1001681B (de) | Verfahren zur Herstellung von 21-Oxypregnanen | |
| DE1803276A1 (de) | Reagens zur Einfuehrung von Methylengruppen | |
| DE1298529B (de) | Verfahren zur Herstellung von ungesaettigten 16-Methylen-17ª‡-alkoxy-3, 20-diketosteroiden der Pregnanreihe |